BOK Financial Private Wealth, Inc.
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1317348
DENVER, CO
Position in REGN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$4,364
+$803 QoQ
Shares Held
7
+40.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,265
of 1,322 holders
Holding Since
Dec 2021
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BOK Financial Private Wealth, Inc. holds $491,806 across 8 Biotechnology names. REGN ranks #3 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
948 | $470,900 | |
| 2 | ARGX |
Argenx SE
|
7 | $6,494 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
7 | $4,364 | |
| 4 | MRNA |
Moderna, Inc.
|
51 | $3,571 | |
| 5 | INCY |
Incyte Corp
|
22 | $2,493 | |
| 6 | GMAB |
Genmab A/S
|
70 | $1,922 | |
| 7 | ONC |
BeOne Medicines Ltd.
|
6 | $1,709 | |
| 8 | TECH |
BIO-TECHNE Corp
|
5 | $353 |
All Filings in REGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,364 | 7 | Shares | Sole | 2026-08-10 | |
| 2024-12-31 | $3,561 | 5 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $43,100 | 41 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $39,939 | 38 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $36,574 | 38 | Shares | Sole | 2024-05-01 | |
| 2022-03-31 | $366,670 | 525 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $216,611 | 343 | Shares | Sole | 2022-02-15 | |
| No filing history on record for this holder in this stock. | ||||||